Lu Bing-Han, Liu Hui-Bing, Guo Shu-Xun, Zhang Jie, Li Dong-Xu, Chen Zhi-Gang, Lin Fei, Zhao Guo-An
Department of Cardiology, Life Science Center, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
Key Laboratory of Cardiovascular Injury and Repair Medicine of Henan, Weihui, China.
Front Cardiovasc Med. 2022 Aug 26;9:959955. doi: 10.3389/fcvm.2022.959955. eCollection 2022.
Long non-coding RNA (lncRNAs) are longer than 200 nucleotides and cannot encode proteins but can regulate the expression of genes through epigenetic, transcriptional, and post-transcriptional modifications. The pathophysiology of smooth muscle cells can lead to many vascular diseases, and studies have shown that lncRNAs can regulate the phenotypic conversion of smooth muscle cells so that smooth muscle cells proliferate, migrate, and undergo apoptosis, thereby affecting the development and prognosis of vascular diseases. This review discusses the molecular mechanisms of lncRNA as a signal, bait, stent, guide, and other functions to regulate the phenotypic conversion of vascular smooth muscle cells, and summarizes the role of lncRNAs in regulating vascular smooth muscle cells in atherosclerosis, hypertension, aortic dissection, vascular restenosis, and aneurysms, providing new ideas for the diagnosis and treatment of vascular diseases.
长链非编码RNA(lncRNAs)长度超过200个核苷酸,不能编码蛋白质,但可通过表观遗传、转录和转录后修饰来调控基因表达。平滑肌细胞的病理生理学可导致多种血管疾病,研究表明lncRNAs可调节平滑肌细胞的表型转化,使平滑肌细胞增殖、迁移并发生凋亡,从而影响血管疾病的发生发展及预后。本文综述讨论了lncRNA作为信号、诱饵、支架、向导等功能调控血管平滑肌细胞表型转化的分子机制,并总结了lncRNAs在动脉粥样硬化、高血压、主动脉夹层、血管再狭窄和动脉瘤中调控血管平滑肌细胞的作用,为血管疾病的诊断和治疗提供新思路。